| Announce Date | 01/29/2026 |
| EPS Normalized Actual | $-0.09 (Beat by $0.04) |
| EPS GAAP Actual | $-0.09 (Beat by $0.04) |
| Revenue Actual | $1.541B |
| Revenue Surprise | Beat by $1541M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.3195 |
| EPS GAAP Estimate | $0.3195 |
| Revenue Estimate | $2.0415834B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 1.88 | 14.11 | 1.7854 | 1.97469 | 1 |
| Dec 2028 | 1.1 | 24.11 | 1.05812 | 1.18966 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.1 | -0.2547 | 1.541B | -10.84% | -592.56M |
| FQ3 2025 (Sep 2025) | 0.11 | -0.23715 | 1.717B | -81.25% | -433.03M |
| FQ2 2025 (Jun 2025) | 0.12 | -0.2273 | 1.884B | -2.92% | -253.15M |
| FQ1 2025 (Mar 2025) | 0.11 | 0.11 | 0.335B | -866.27% | 335M |
| FQ4 2024 (Dec 2024) | 0.11 | 0.11 | 1.708B | -3.86% | 1708M |
| FQ3 2024 (Sep 2024) | 0.04 | 0.04 | 3.112B | -13.82% | 3112M |
| FQ2 2024 (Jun 2024) | 0.24 | 0.24 | 1.939B | -2.99% | 1939M |
| FQ1 2024 (Mar 2024) | 0.0002 | 0.0002 | 3.237B | 41.89% | 3237M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.3195
Consensus Revenue Estimates
2.0415834B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.26 | -- | 0.2528 | 0.26919 | 3 |
| FQ3 2027 (Sep 2027) | 0.39 | -- | 0.37921 | 0.40378 | 3 |
| FQ2 2027 (Jun 2027) | 0.42 | -- | 0.40838 | 0.43484 | 3 |
| FQ1 2027 (Mar 2027) | 0.38 | -- | 0.36948 | 0.39343 | 3 |
| FQ4 2026 (Oct 2026) | 0.4389 | 77.22 | 0.42163 | 0.46086 | 3 |
| FQ3 2026 (Jul 2026) | 0.4459 | 75.33 | 0.42835 | 0.46821 | 4 |
| FQ2 2026 (Jun 2026) | 0.4459 | 73.09 | 0.42519 | 0.47563 | 4 |
| FQ1 2026 (Mar 2026) | 0.3195 | 65.57 | 0.30466 | 0.3408 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.01B | -- | 1.97B | 2.06B | 2 |
| FQ3 2027 (Sep 2027) | 2.18B | -- | 2.13B | 2.24B | 2 |
| FQ2 2027 (Jun 2027) | 2.25B | -- | 2.2B | 2.31B | 2 |
| FQ1 2027 (Mar 2027) | 2.09B | -- | 2.05B | 2.15B | 2 |
| FQ4 2026 (Oct 2026) | 2.25B | 31.61 | 2.18B | 2.34B | 4 |
| FQ3 2026 (Jul 2026) | 2.29B | 24.91 | 2.22B | 2.37B | 4 |
| FQ2 2026 (Jun 2026) | 2.29B | 17.6 | 2.2B | 2.4B | 4 |
| FQ1 2026 (Mar 2026) | 2.04B | 83.59 | 1.97B | 2.15B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.3547 | 0.1 | -0.2547 | -254.7% |
| FQ3 2025 (Sep 2025) | 0.34715 | 0.11 | -0.23715 | -215.59% |
| FQ2 2025 (Jun 2025) | 0.3473 | 0.12 | -0.2273 | -189.42% |
| FQ1 2025 (Mar 2025) | 0.11 | 0.11 | 100% | |
| FQ4 2024 (Dec 2024) | 0.11 | 0.11 | 100% | |
| FQ3 2024 (Sep 2024) | 0.04 | 0.04 | 100% | |
| FQ2 2024 (Jun 2024) | 0.24 | 0.24 | 100% | |
| FQ1 2024 (Mar 2024) | 0.0002 | 0.0002 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $2.13B | $1.54B | $-592.56M | -38.45% |
| FQ3 2025 (Sep 2025) | $2.15B | $1.72B | $-433.03M | -25.22% |
| FQ2 2025 (Jun 2025) | $2.14B | $1.88B | $-253.15M | -13.44% |
| FQ1 2025 (Mar 2025) | $0B | $0.34B | $335M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.71B | $1708M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.11B | $3112M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.94B | $1939M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.24B | $3237M | 100% |